U.S. state attorneys general said on Thursday that Johnson & Johnson and its unit had agreed to pay nearly US$117 million to settle litigation over deceptive marketing of the company’s transvaginal surgical mesh devices.
U.S. state attorneys general said on Thursday that Johnson & Johnson and its unit had agreed to pay nearly US$117 million to settle litigation over deceptive marketing of the company’s transvaginal surgical mesh devices.